Tu sei qui

Home » Gyeonggi-Do

Neurotech Pharmaceutical Co. Ltd.

Neurotech Pharmaceutical Co. Ltd. è un Korea del Sud azienda, si trova in 29-35, Woncheon-dong, Yeongtong-gu. più dettagli come il seguente

Informazioni sulla società

  • Nome dell'Azienda: Neurotech Pharmaceutical Co. Ltd.
  • Paese: South Korea
  • Indirizzo: 29-35, Woncheon-dong, Yeongtong-gu
  • Codice di Aree internazionali: 82
  • Telefono: 031-217-3828 (+82-031-217-3828)
  • Fax: 031-217-3829 (+82-031-217-3829)
  • Contatto: Gwak Byung Joo
  • Posizione: Ceo
  • Sito:
  • Profilo: Dr. Robert Abbott Visited Neurotech Pharmaceuticals May 3 To May 6 As Neurotech’ Personnel Review Of Ceo Candidates Was Coming To Close. Dr. Abbott Was Agreed To Be The First Ceo Of Amkor Pharmaceuticals Inc. A Company Neurotech Is Planning To Set Up In Usa. During His Stay, Dr. Abbott Concluded His Service Agreement And Met Members Of Neurotech Research Committee. He Was, In Spite Of Tight Schedule, Able To Learn In Depth About Neurotech’s Science And Technology Of Neu2000, Neu2072, And Neugi. He Also Had Discussions As Regards Developmental Plans Of The Products And Clinical Trial Plans In Particular. Neurotech’ S Determination To Launce Its Business Base In Usa Is Carefully Prepared To Overcome Limitations In Experience And Investment Of Korean Pharmaceutical Industry Since Late 2002. As The Newly Appointed Ceo Incorporates Amkor Pharmaceuticals Inc. And Sets Organization Of Staffs In Motion By The Middle Of May, Our Clinical Trial And Investment At Site Are Placed Within This Year As Planned. Amkor Pharmaceuticals Inc. Targets Its Nasdaq Listing And Licensing Out In 2007. Such A Success Definitely Gives New Visions To Korean Inferior Pharmaceutical Industry And Uplifts It To A Worldwide Level. Proven Pharmacological And Competitive Supremacy Of Neurotech’s New Drug Candidates In Us Market Is What Let Us Have Such High Expectation. Dr. Abbott Mentioned That His Decision To Join Neurotech Was Based On Strong Confidence In The Candidates After His Own Deliberate Research Of Them. Dr. Abbott The First Ceo Has Pioneered Bioventure Last 20 Years. He Has Served Three Bioventures As Ceo And Has Listed Two Of Them To Nasdaq. Not To Mention His Valuable Experience In Business Setups And Exchanges, His Well Tractable Experience In Drug Development Will Adds A Lot To The Future Of Neurotech’s World Level Compounds Of Neu2000, Neu2072, And Neugi. As Amkor Pharmaceuticals Inc. Contributes More Business Development, Neurotech Can Be Better Concentrated On Research Development. We Promise That Neurotech Will Grow To Be One Of The World Best Pharmaceutical Companies For The Enhancement Of Human Health And Happiness.
  • Area: Gyeonggi-Do
Altri Link

  • Neuronfit Co. Ltd.
  • Neurotech Co. Ltd.
  • Neurotech Pharmaceutical Co. Ltd.
  • Nevico Co. Ltd.
  • Nevis Medical Co. Ltd.

    •         ‹ precedente | seguente ›